Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:percentage of study population developing leukemia during a period of time
go back to main search page
Accession:CMO:0001267 term browser browse the term
Definition:The number of new cases of leukemia, any of a group of progressive, malignant diseases of the blood-forming organs, marked by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow, appearing in a study population during a certain period compared to the total number of individuals in the study population, expressed as a percentage.
Synonyms:related_synonym: leukemia incidence
 xref: MESH:D007938



show annotations for term's descendants           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    disease population measurement 57
      disease incidence/prevalence measurement 57
        leukemia incidence/prevalence measurement 0
          percentage of study population developing leukemia during a period of time 0
            percentage of study population developing myeloid leukemia during a period of time 0
paths to the root